Document is current
Any future updates will be listed below
-
Authors
Zhan, Yanxia
Cao, Jingjing
Ji, Lili
Zhang, Miaomiao
Shen, Qi
Xu, Pengcheng
Zhuang, Xibing
Qin, Shanshan
Hua, Fanli
Sun, Lihua
Li, Feng
Chen, Hao
Cheng, Yunfeng
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81500090, 81878898)
Science and Technology Commission of Shanghai Municipality (21ZR1459000)
Program of the Shanghai Academic/Technology Researcher leader (20XD1401000)
Shanghai Engineering Research Center of Tumor Multi-Target Gene Diagnosis (20DZ2254300)
Key Subject Construction Program of Shanghai Health Administrative Authority (ZK2019B30)
- License Information
-
More Information
Article History
Received: 15 May 2022
Accepted: 18 August 2022
First Online: 1 September 2022
Declarations
:
: The study was in accordance with the ethical standards formulated in the Helsinki Declaration and was approved by the Institutional Review Board of Zhongshan Hospital, Fudan University (# B2021-694R). Written informed consent was obtained from each participant upon enrollment.
: Not applicable.
: The authors declare that there is no competing interests regarding the publication of this paper.
